research Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.
Maurício de Nassau, PE, Brazil
Niterói, RJ, Brazil
Volta Redonda, RJ, Brazil
Ribeirão Preto, SP, Brazil
Salvador, BA, Brazil
Varginha, MG, Brazil